Back to Ask the Diabetes Team Ask the Diabetes Team

From Erie, Pennsylvania, USA::

I was diagnosed with Type II Diabetes 10 years ago. I've been able to keep by blood sugars in control wit Glyburide (1.5 mg/day). The past year by A1C results have consistently been climbing from 6.3 to 7.0 and now 8.5 even after my doctor has doubled by Glyburide. He has now put me on Actos and I've read a lot about its effectiveness, but I've also read that after 10 years (at least before Actos and other similar drugs) that not much change can be expected. Perhaps Actos is different and can help get my blood sugars down where they belong. I do all the right things -- diet, exercise, etc. Any information you can provide will be most appreciated.


Your doctor is smart to put you on a second agent that will enhance the effect of the insulin secretagogue you are already taking. The glyburide helps you make more insulin and the Actos makes the insulin more sensitive in the muscle and fat cells. They can work together to help bring your A1Cs back down. The only problem you may have is that you cannot make enough of your own insulin to do the job. This happens over time when you have Type 2 diabetes. If that is the case, your doctor may want to start you on insulin or try an additional agent such as metformin which will also make your insulin more sensitize, especially in the liver.


Original posting 7 Dec 2003
Posted to Type 2 and Pills for Diabetes


  Home Return to Top

Last Updated: Tuesday April 06, 2010 15:09:52
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.